Dr. David Pyle

M.D., PH.D. | Pediatric Allergy-Immunology | Male

Dr. David Pyle, M.D., PH.D. is a Boston, Massachusetts based Pediatric doctor with medical specialization in Pediatric Allergy-Immunology. Current practice location of Dr. David Pyle is 275 Cambridge St Ste 530, Boston, Massachusetts - 02114-3130. He can be contacted on phone at 617-726-8707 and fax number 617-726-2803. Dr. David Pyle is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. David Pyle is 1902284029 which was assigned by NPPES on 08 May, 2015 and it was last updated on 06 Mar, 2020. Dr. David Pyle license number is 276776 for Pediatrics Pediatric Allergy/Immunology (2080P0201X) in Massachusetts.
Dr. David Pyle specializes in the diagnosis and treatment of allergies, allergic reactions, and immunologic diseases in children.
Complete Profile:
Dr. David Pyle basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Allergy/Immunology
Provider Name :Dr. David Pyle
Credential :M.D., PH.D.
Gender :Male
Sole Proprietor : Yes
Business Address:
Dr. David Pyle address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :275 Cambridge St Ste 530
Boston, MA, 02114-3130
United States
Phone Number :617-726-8707
Fax Number :617-726-2803
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1902284029
NPI Entity Type : Individual
First Enrolment Date : 08 May, 2015
Last Updated On : 06 Mar, 2020
Medicare Participation:
Dr. David Pyle participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :5991017576
Medicare Enrollment ID :I20200714003164
Primary Specialty :Allergy/immunology
Medical School :Other
Graduation Year :2015
Accepts Medicare?Yes. Dr. David Pyle accepts medicare insurance.
Group Practice Association:
Dr. David Pyle is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. David Pyle is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Massachusetts General Physicians Organization Inc2466365820293855 Fruit St
Boston, MA - 021142696
Ph: 6177240287
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. David Pyle are as mentioned. Primary taxonomy code for Dr. David Pyle, M.D., PH.D. is 2080P0201X (Pediatrics Pediatric Allergy/Immunology).
Taxonomy Code SpecialityPrimaryLicense No.State
207RA0201XInternal Medicine Allergy & ImmunologyNo276776MA
208000000XPediatricsNo276776MA
2080P0201XPediatrics Pediatric Allergy/ImmunologyYes276776MA
Other Practice Locations:
Practice AddressCity, StatePhone Number
55 FRUIT ST, COX 201
BOSTON, MA, 02114-2696
United States
BOSTON, MA617-726-3850
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :275 Cambridge St Ste 530
Boston, MA, 02114-3130
United States
Phone Number :617-726-8707
Fax Number :617-726-2803
Business Location:
Patients can refer following map for directions to Dr. David Pyle practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.